Developing Natural Solutions for Human Health®
We are developing enhanced therapeutics for treating cancers and their side effects, infectious diseases such as HIV and Influenza, and CNS disorders. We also manufacture quality-of-life medicines for health maintenance, research chemicals for standards, APIs for pharmaceuticals and equipment for our enabling technology platforms. Over two decades (1981-2002) and covering all diseases, countries and sources, 52% of the 1,031 new molecular entities (NMEs), 60% of anticancer drugs and 68.5% of anti-infectives approved by regulatory authorities were based on natural products isolated from terrestrial plants and microorganisms.
We source the next generation of enhanced therapeutics from tropical rainforests to temperate woods, deep-sea environments such as the hydrothermal vents, and from the plant and animal kingdoms. Utilizing our enabling technology platforms, we are developing enhanced therapeutics for:
- Oncology and Supportive Care for treating/preventing certain cancers and chemotherapy side effects.
- Infectious Diseases including HIV, influenza, and MRSA.
- CNS Disorders such as Alzheimer’s Disease, Cognition, Depression and Pain.
- QOL Medicines such as dietary supplements or nutraceuticals.
We will co-develop our leads with commercial partners and/or utilize our enabling technology platforms and drug development strategies to develop your enhanced therapeutics. We also manufacture and will provide for your development: